• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    3.58 Up 0.13(3.77%) Jul 31, 4:00PM EDT
    |After Hours : 3.64 Up 0.06 (1.68%) Jul 31, 7:52PM EDT
    Add to Portfolio
    Prev Close:3.45
    Open:3.46
    Bid:3.00 x 1900
    Ask:3.64 x 2000
    1y Target Est:6.50
    Beta:2.29
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:3.43 - 3.61
    52wk Range:1.94 - 5.48
    Volume:966,804
    Avg Vol (3m):1,714,120
    Market Cap:421.99M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IDRA

    Comparison

    Symbol% ChgMkt Cap
    IDRAUp 3.77%421.99M
    DVAXUp 0.65%984.38M
    PFEUp 0.92%222.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3,910.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.46
    Quarterly EPS Est (Jun-15) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback